Our understanding of diabetes has taken some significant strides recently, but a new discovery has the potential to significantly improve the screening process by giving us a more complete picture of the disease. Working out the University of Lincoln in the UK, a team was able to identify the fifth and final molecule attacked by the immune system in Type 1 of the condition...With Tetraspanin-7 identified as the fifth molecule, future screening methods can include it, potentially making them significantly more accurate, while providing more information about the patient's specific immune response, which can help inform treatment choices.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)